Multi-Vitamin
- Manufacturer
- LLC Federal Solutions | Silarx Pharmaceuticals, Inc
- Effective date
- 2013-08-20
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:39:58
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Supplement Facts
Serving Size: 5 mL (1 teaspoonful)
OTC - ACTIVE INGREDIENT SECTION
Amount per 5 mL (1 teaspoonful) % Daily Value*
Vitamin A (as Palmitate)................................................. 2250 IU 45%
Vitamin C (as Ascorbic Acid).......................................... 54 mg 90%
Vitamin D (as Cholecalciferol)........................................ 360 IU 90%
Vitamin E (as dl-α-Tocopheryl Acetate).......................... 13.5 IU 45%
Thiamin (B1) (as Thiamine Hydrochloride)..................... 0.842 mg 56%
Riboflavin (B2) (as riboflavin-5-Phosphate Sodium)....... 1.08 mg 64%
Niacin (as Niacinamide)....................................... ……… 12.2 mg 61%
Vitamin (B6) (as Pyridoxine Hydrochloride)................... 0.945 mg 47%
Vitamin B12 (as Cyanocobalamin).................................. 4.05 mcg 68%
Percent Daily Values are based on a 2,000 calorie diet. *% U.S. Daily Values
OTC - PURPOSE SECTION
Purpose
Vitamin Supplement
INDICATIONS & USAGE SECTION
Uses
Supplementation of the diet with nine essential vitamins
WARNINGS SECTION
WARNINGS
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN.
OTC - STOP USE SECTION
In case of overdose, get medical help or contact a Poison Control Center right away. Stop use and consult a doctor if you experience any adverse reaction.
DOSAGE & ADMINISTRATION SECTION
Directions
Adults: one teaspoonful (5mL), or as directed by your doctor. Ask a doctor before use in children under 12 years of age.
INACTIVE INGREDIENT SECTION
Other Ingredients: Purified water, glycerin, polysorbate 80, propylene glycol, polysorbate 20, methylparaben, saccharin sodium, sodium benzoate, sodium carboxymethylcellulose, caramel, lemon flavor. Sodium citrate may be added to adjust pH.
OTHER SAFETY INFORMATION
Other information
Shake Well before Use
Store below 77ºF (25ºC)
Manufactured by: Silarx Pharmaceuticals, Inc.
19 West Street, Spring Valley, NY 10977
Distributed by: LLC Federal Solutions
14 NE 1st Ave., Miami, FL 33132
Questions: call 1-855-333-6337
REV 109-00
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
NDC: 24451-008-05
MULTIVITAMIN SUPPLEMENT
(MULTI-DELYN)
LIQUID
DELIVERS 5 mL
LEMON FLAVOR
SHAKE WELL BEFORE USE
NO SUGAR, NO ALCOHOL ADDED
Exp: 00/00/00 Lot # 00000
Mfg By: Silarx Pharmaceuticals, Inc.
Spring Valley, NY 10977 USA
Dist. By: LLC Federal Systems
Miami, FL 33132
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 24451-008-05 | 2020-01-07 | C162847 | 48780-1 | 9855d018-eb3a-cd31-e053-dbdaa90ab51a | c5125394-da88-4bf0-b537-38ebbb5104cc |
| 24451-008-05 | 2019-11-27 | C162847 | 48780-1 | 9855d018-eb3a-cd31-e053-dbdaa90ab51a | c5125394-da88-4bf0-b537-38ebbb5104cc |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .ALPHA.-TOCOPHEROL | ACTIVE INGREDIENT | H4N855PNZ1 | 4 | |
| ASCORBIC ACID | ACTIVE INGREDIENT | PQ6CK8PD0R | 4 | |
| CYANOCOBALAMIN | ACTIVE INGREDIENT | P6YC3EG204 | 4 | |
| NIACIN | ACTIVE INGREDIENT | 2679MF687A | 4 | |
| PYRIDOXINE | ACTIVE INGREDIENT | KV2JZ1BI6Z | 4 | |
| RIBOFLAVIN | ACTIVE INGREDIENT | TLM2976OFR | 4 | |
| THIAMINE | ACTIVE INGREDIENT | X66NSO3N35 | 4 | |
| VITAMIN A | ACTIVE INGREDIENT | 81G40H8B0T | 4 | |
| VITAMIN D | ACTIVE INGREDIENT | 9VU1KI44GP | 4 | |
| .ALPHA.-TOCOPHEROL | ACTIVE MOIETY | H4N855PNZ1 | 4 | |
| ASCORBIC ACID | ACTIVE MOIETY | PQ6CK8PD0R | 4 | |
| CHOLECALCIFEROL | ACTIVE MOIETY | 1C6V77QF41 | 4 | |
| CYANOCOBALAMIN | ACTIVE MOIETY | P6YC3EG204 | 4 | |
| NIACIN | ACTIVE MOIETY | 2679MF687A | 4 | |
| PYRIDOXINE | ACTIVE MOIETY | KV2JZ1BI6Z | 4 | |
| RIBOFLAVIN | ACTIVE MOIETY | TLM2976OFR | 4 | |
| THIAMINE ION | ACTIVE MOIETY | 4ABT0J945J | 4 | |
| VITAMIN A | ACTIVE MOIETY | 81G40H8B0T | 4 | |
| CARAMEL | INACTIVE INGREDIENT | T9D99G2B1R | 4 | |
| CARBOXYMETHYLCELLULOSE SODIUM | INACTIVE INGREDIENT | K679OBS311 | 4 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 4 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 4 | |
| POLYSORBATE 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 4 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 4 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 4 | |
| SACCHARIN SODIUM | INACTIVE INGREDIENT | SB8ZUX40TY | 4 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | 4 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | 4 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 4 |
Products#
Every source-derived product name is available through these pages.
- Multi-Vitamin
- vitamin A, vitamin C, vitamin D, Vitamin E, thiamine, riboflavin, niacin, pyridoxine, and cyanocobalamin
- VITAMIN A
- ASCORBIC ACID
- VITAMIN D
- CHOLECALCIFEROL
- .ALPHA.-TOCOPHEROL
- THIAMINE
- THIAMINE ION
- RIBOFLAVIN
- NIACIN
- PYRIDOXINE
- CYANOCOBALAMIN
- WATER
- GLYCERIN
- POLYSORBATE 80
- PROPYLENE GLYCOL
- POLYSORBATE 20
- METHYLPARABEN
- SACCHARIN SODIUM
- SODIUM BENZOATE
- CARBOXYMETHYLCELLULOSE SODIUM
- CARAMEL
- SODIUM CITRATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 24451-008 | 24451-008-05 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| VITAMIN A | 81G40H8B0T | ACTIB |
| ASCORBIC ACID | PQ6CK8PD0R | ACTIB |
| VITAMIN D | 9VU1KI44GP | ACTIB |
| .ALPHA.-TOCOPHEROL | H4N855PNZ1 | ACTIB |
| THIAMINE | X66NSO3N35 | ACTIB |
| RIBOFLAVIN | TLM2976OFR | ACTIB |
| NIACIN | 2679MF687A | ACTIB |
| PYRIDOXINE | KV2JZ1BI6Z | ACTIB |
| CYANOCOBALAMIN | P6YC3EG204 | ACTIB |
| WATER | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| POLYSORBATE 20 | 7T1F30V5YH | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| SACCHARIN SODIUM | SB8ZUX40TY | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | IACT |
| CARAMEL | T9D99G2B1R | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | FILM / BUCCAL | 1 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 60 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SOLUTION / OPHTHALMIC | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE / ORAL | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / ORAL | 27120 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PERINEURAL | 80 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SOLUTION / ORAL | 3480 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 100 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | TABLET, FILM COATED / ORAL | 0.35 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / OPHTHALMIC | 1 %w/v | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | CAPSULE / ORAL | 563 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET / BUCCAL | 4 mg | ||
| SACCHARIN SODIUM | SACCHARIN SODIUM | SB8ZUX40TY | POWDER, FOR SUSPENSION / ORAL | 85 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION / INTRA-ARTICULAR | 4 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, FOR SUSPENSION / ORAL | 120 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / OPHTHALMIC | 0.05 %w/w | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET, DELAYED RELEASE / ORAL | 280 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SOLUTION/ DROPS / OPHTHALMIC | 2 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / SOFT TISSUE | 4 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION, SOLUTION / INTRAMUSCULAR | 4.8 %w/v | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / INTRAMUSCULAR | 1.62 %w/v | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | FILM, SOLUBLE / BUCCAL | 3 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRA-ARTICULAR | 0.24 %w/v | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION / INTRAVENOUS | 864 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CREAM / TOPICAL | 3000 mg | ||
| SACCHARIN SODIUM | SACCHARIN SODIUM | SB8ZUX40TY | GEL / DENTAL | 0.3 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LOTION, AUGMENTED / TOPICAL | 2070 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION, EXTENDED RELEASE / ORAL | 40 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 900 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SPRAY, METERED / NASAL | 40 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / AURICULAR (OTIC) | 0.01 %w/w | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION, EMULSION / INTRAVENOUS | 0.1 %w/v | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | CAPSULE, LIQUID FILLED / ORAL | 24 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / NASAL | 26 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION/ DROPS / OPHTHALMIC | 0.05 %w/w | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION / INTRASYNOVIAL | 0.1 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SHAMPOO / TOPICAL | 8 %w/w | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | POWDER, FOR SUSPENSION / ORAL | 560 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, ORALLY DISINTEGRATING / ORAL | 1 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SOLUTION / AURICULAR (OTIC) | 0.2 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CREAM, AUGMENTED / TOPICAL | 2 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / ORAL | 660 mg | ||
| SACCHARIN SODIUM | SACCHARIN SODIUM | SB8ZUX40TY | LIQUID / ORAL | 3 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / INTRASYNOVIAL | 4 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / PARENTERAL | 30 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / SUBCUTANEOUS | 0.16 %w/v | ||
| SACCHARIN SODIUM | SACCHARIN SODIUM | SB8ZUX40TY | OINTMENT / DENTAL | NA | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET / SUBLINGUAL | 0.08 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GEL / TOPICAL | 24 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / INTRAVENOUS | 30 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR | 4 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 46557d9b-ba31-4f41-9012-0f8452a58bfc | c5125394-da88-4bf0-b537-38ebbb5104cc | 2013-08-20 | Warnings | 46557d9b-ba31-4f41-9012-0f8452a58bfc c5125394-da88-4bf0-b537-38ebbb5104cc |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
